Search Media Items

Resumen de información revisada por expertos sobre el uso del cardo mariano como tratamiento para personas con cáncer.

A summary of interim results from a phase III trial testing ribociclib plus letrozole (Femara®) as a first-line treatment for postmenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer.

An article about a host of new treatment options that have been produced in the last several years for patients with the skin cancer melanoma.

An NCI research update about research to investigate what factors play a role in “chemobrain” or cognitive impairment after cancer treatment.

While at FDA, fellows are assigned a mentor who is a senior member of FDA scientific review staff. Learn more about mentors for Tracks 1 and 2.

NCI and FDA collaborate to train scientists in research and research-related regulatory review. Meet the current IOTF fellows.

While at FDA, fellows are assigned a mentor who is a senior member of FDA scientific review staff. Learn more about mentors for Tracks 3 and 4.

Actualización acerca de la investigación de los factores que tienen una función en el

Resumen de información revisada por expertos sobre el uso del 714-X como tratamiento para personas con cáncer. Nota: La información contenida en este sumario ya no se actualiza y se ofrece solo con fines de consulta.

NCI is accepting applications for research grants that support the Cancer Moonshot Blue Ribbon Panel recommendations to accelerate cancer research.